Atlas Trials

Gallium-68 Labeled LM3 PET/CT in Neuroendocrine Tumors

Clinical trial NCT04318561 · COMPLETED

Trial details

NCT number
NCT04318561
Sponsor
Peking Union Medical College Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2019-12-01
Primary completion
2021-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.